Prostate Cancer - Results from #21160

Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer - Abstract April 17, 2014

Seminal vesicle intraepithelial neoplasia versus basal cell hyperplasia in a seminal vesicle - Abstract April 17, 2014

Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: Results from a phase 2 nonrandomized expansion cohort - Abstract April 17, 2014

NIH-funded study shows increased survival in men with metastatic prostate cancer who receive chemotherapy when starting hormone therapy April 17, 2014

Implementing newer agents for the management of castrate-resistant prostate cancer: What is known and what is needed? - Abstract April 15, 2014

Laser ablation as focal therapy for prostate cancer - Abstract April 15, 2014

A modified point count method as a practical approach to assess the tumor volume and the percent gland involvement by prostate carcinoma - Abstract April 15, 2014

The prognostic significance of Gleason scores in metastatic prostate cancer - Abstract April 15, 2014

Prevalence and risk of cancer of incidental uptake in prostate identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography - Abstract April 15, 2014

Visualization of periprostatic nerve fibers before and after radical prostatectomy using diffusion tensor magnetic resonance imaging with tractography - Abstract April 15, 2014

Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance - Abstract April 15, 2014

Development and validation of a scoring system for late anorectal side-effects in patients treated with radiotherapy for prostate cancer - Abstract April 15, 2014

ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer - Abstract April 15, 2014

EAU 2014 - Effects of radium-223 dichloride (Ra-223) on total alkaline phosphatase and prostate-specific antigen in patients with castration-resistant prostate cancer and symptomatic bone metastases from the phase 3 ALSYMPCA trial - Session Highlights April 15, 2014

Long-term survival of participants in the Prostate Cancer Prevention Trial, Silberstein and Sartor - Abstract April 14, 2014

Depression and anxiety in prostate cancer: A systematic review and meta-analysis of prevalence rates - Abstract April 14, 2014

Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise - Abstract April 14, 2014

Pre-screening age African-American males: What do they know about prostate cancer screening, knowledge, and risk perceptions? - Abstract April 14, 2014

A novel randomised controlled trial design in prostate cancer - Abstract April 14, 2014

The dosimetric effects of photon energy on the quality of prostate volumetric modulated arc therapy - Abstract April 14, 2014

Page 1059 of 1455